Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

All MBC

• • NP-G2-044 in Patients With Advanced Breast Cancer

Triple-Negative

• • Targeted Therapy GSK3326595 for Advanced HER2- Breast (and Other) Cancers
  • Taxol Alone or With Ipatasertib and/or Atezolizumab in Advanced Triple Negative Breast Cancer
  • BT5528 Alone or With Nivolumab in Advanced Triple Negative Breast Cancer That Tests EphA2+
  • Targeted Therapy PMD-026 for Metastatic Triple Negative Breast Cancer
  • mRNA-2752 & Durvalumab for Advanced Triple Negative Breast Cancer
  • Entinostat & Capecitabine for Stage II, Stage III or Metastatic HER2 Negative Breast Cancer

HR Positive (HR+)

• • Palbociclib, & Fulvestrant With or Without GDC-0077 in Advanced HR+, HER2- Breast Cancer with a PIK3CA mutation 
  • Targeted Therapy GSK3326595 for Advanced HER2- Breast (and Other) Cancers
  • Entinostat & Capecitabine for Stage II, Stage III or Metastatic HER2 Negative Breast Cancer

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.

Last Modified on August 25, 2020